Theerth Vikas Srinivasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Theerth Vikas Srinivasan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Annabella Natalini
Department of Chemistry and Biochemistry, Augusta University, Augusta, GA 30912, USA
1 shared publication - Bal. L. Lokeshwar
Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA
1 shared publication - Guido F. Verbeck
Department of Chemistry and Biochemistry, Augusta University, Augusta, GA 30912, USA
1 shared publication - Kunj Bihari Gupta
Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA
1 shared publication - Nihal Amineni
Department of Chemistry and Biochemistry, Augusta University, Augusta, GA 30912, USA
1 shared publication - Rajeev Sakhuja
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Rajasthan, 333031, India
1 shared publication
Latest Publications
- Open Access
Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy
Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid, exhibits potent anticancer properties; however, its poor solubility and bioavailability limit its therapeutic application. To overcome these challenges and facilitate molecular target identification, a set of biotin-conjugated UA derivatives (5a–d) was synthesized through selective C-28 alkylation and biotinylation. The use of microwave-assisted synthesis significantly enhanced both reaction efficiency and product purity. Among the derivatives, compound 5c exhibited increased cytotoxicity and selectivity against bladder cancer cell lines, surpassing UA in its ability to induce apoptosis, generate reactive oxygen species (ROS), and halt cell cycle progression at the G1 phase. Proteomic profiling revealed that 5c interacts with proteins involved in ER stress, RNA processing, cytoskeletal remodeling, and metabolic regulation. These findings underscore the potential of biotinylated UA derivatives as multifunctional chemical probes for mechanistic studies in the development of targeted therapies for cancer.
Open AccessBiotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy
Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid, exhibits potent anticancer properties; however, its poor solubility and bioavailability limit its therapeutic application. To overcome these challenges and facilitate molecular target identification, a set of biotin-conjugated UA derivatives (5a–d) was synthesized through selective C-28 alkylation and biotinylation. The use of microwave-assisted synthesis significantly enhanced both reaction efficiency and product purity. Among the derivatives, compound 5c exhibited increased cytotoxicity and selectivity against bladder cancer cell lines, surpassing UA in its ability to induce apoptosis, generate reactive oxygen species (ROS), and halt cell cycle progression at the G1 phase. Proteomic profiling revealed that 5c interacts with proteins involved in ER stress, RNA processing, cytoskeletal remodeling, and metabolic regulation. These findings underscore the potential of biotinylated UA derivatives as multifunctional chemical probes for mechanistic studies in the development of targeted therapies for cancer.